Enanta Pharmaceuticals Inc (NASDAQ:ENTA) appears in 127 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 7,568,110 | 3,838,451 | 102.92% | $95,433,868.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,103,768 | 27,486 | 0.89% | $39,200,591.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,871,862 | 99,600 | 3.59% | $36,271,617.00 |
| Krensavage Asset Management, LLC | 31 Mar, 2026 | 2,866,138 | 99,748 | 3.61% | $36,199.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 1,956,867 | 0 | 0.00% | $24,715,230.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,178,049 | 1,178,049 | 0.00% | $14,878,759.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 948,904 | 948,904 | 0.00% | $11,984,658.00 |
| Spruce Street Capital LP | 31 Mar, 2026 | 932,598 | 542,911 | 139.32% | $11,778,713.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 882,097 | 211,669 | 31.57% | $11,140,885.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 880,023 | -5,103 | -0.58% | $11,102.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 725,061 | 79,270 | 12.27% | $9,159,559.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 665,258 | 23,058 | 3.59% | $8,402,209.00 |
| State Street Corp | 31 Mar, 2026 | 562,106 | 38,391 | 7.33% | $7,099,399.00 |
| Hillsdale Investment Management Inc. | 31 Mar, 2026 | 435,510 | 13,210 | 3.13% | $5,500,491.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 313,157 | 78,322 | 33.35% | $3,955,173.00 |
| Morgan Stanley | 31 Mar, 2026 | 309,511 | -30,407 | -8.95% | $3,909,132.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 294,971 | 76,335 | 34.91% | $3,725,484.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 267,364 | -18,084 | -6.34% | $3,376,807.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 265,088 | -172,544 | -39.43% | $3,348,062.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 262,533 | 169,375 | 181.81% | $3,315,791.00 |